iShares Genomics Immunology and Healthcare ETF (IDNA) Institutional Ownership $21.15 -0.19 (-0.89%) Closing price 08/8/2025 04:10 PM EasternExtended Trading$21.15 0.00 (0.00%) As of 08/8/2025 05:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock Institutional Ownership Changes (13F Filings) for iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA)Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$947.90KNumber ofInstitutional Sellers(last 12 months)0 Get IDNA Insider Trade Alerts Want to know when executives and insiders are buying or selling iShares Genomics Immunology and Healthcare ETF stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data IDNA Institutional Buying and Selling by Quarter iShares Genomics Immunology and Healthcare ETF Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/22/2025 Cambridge Investment Research Advisors Inc.19,797$406K0.0%+4.0%0.374% 2/17/2025Ameriprise Financial Inc.71,832$1.63M0.0%+23.6%1.228% 1/17/2025 Avior Wealth Management LLC26,650$603K0.0%+180.5%0.456% 11/8/2024 Avior Wealth Management LLC9,500$234K0.0%N/A0.162% 2/5/2024RiverFront Investment Group LLC38,919$896K0.0%-5.2%0.643% 11/15/2023Integrated Wealth Concepts LLC56,879$1.16M0.0%-14.7%0.940% 11/7/2023RiverFront Investment Group LLC41,046$835K0.0%-3.3%0.678% 8/1/2023RiverFront Investment Group LLC42,454$991K0.0%-2.7%0.696% 7/13/2023 Cambridge Investment Research Advisors Inc.32,104$750K0.0%+6.5%0.526% 5/3/2023Integrated Wealth Concepts LLC10,876$253K0.0%N/A0.175% Get the Latest News and Ratings for IDNA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for iShares Genomics Immunology and Healthcare ETF and its competitors with MarketBeat's FREE daily newsletter. 4/28/2023 Janney Montgomery Scott LLC39,360$916K0.0%-3.4%0.635% 3/6/2023OLD Mission Capital LLC5,298$133K0.0%N/A0.086% 2/24/2023RiverFront Investment Group LLC45,602$1.15M0.3%+96.0%0.741% 2/13/2023 Wealthcare Advisory Partners LLC217,907$5.49M0.3%+23.9%3.543% 2/8/2023 Cambridge Investment Research Advisors Inc.29,579$745K0.0%+2.2%0.481% 2/1/2023 Janney Montgomery Scott LLC40,741$1.03M0.0%N/A0.662% 1/31/2023 Westside Investment Management Inc.350$2.51M0.0%-66.7%0.006% 1/26/2023Vigilant Capital Management LLC1,000$25K0.0%N/A0.016% 1/25/2023 Mayflower Financial Advisors LLC21,752$547K0.1%-6.9%0.354% 11/15/2022Flow Traders U.S. LLC11,470$303K0.0%N/A0.178% 11/9/2022 Westside Investment Management Inc.1,050$21.21M0.1%+200.0%0.016% 10/17/2022 Cambridge Investment Research Advisors Inc.28,952$764K0.0%-11.5%0.449% 8/8/2022Baird Financial Group Inc.33,338$963K0.0%-19.4%0.529% 8/2/2022 Triumph Capital Management18,382$160K0.1%N/A0.292% 7/13/2022 Cambridge Investment Research Advisors Inc.32,731$946K0.0%+55.4%0.515% 5/5/2022RiverFront Investment Group LLC24,394$840K0.0%+90.0%0.372% 4/21/2022 Mayflower Financial Advisors LLC29,021$1M0.1%+32.6%0.427% 4/15/2022 Wealthcare Advisory Partners LLC165,681$5.71M0.3%+26.6%2.436% 4/12/2022 Wealthcare Capital Management LLC5,881$203K0.0%N/A0.086% 2/10/2022RiverFront Investment Group LLC12,842$563K0.0%N/A0.183% 2/9/2022Baird Financial Group Inc.50,228$2.20M0.0%+2.8%0.718% 2/3/2022 Cambridge Investment Research Advisors Inc.24,256$1.06M0.0%+6.5%0.342% 2/2/2022 Sigma Planning Corp5,603$245K0.0%-7.6%0.079% 1/21/2022 Mayflower Financial Advisors LLC21,889$959K0.1%+16.6%0.294% 1/20/2022 Parallel Advisors LLC1,168$51K0.0%+106.4%0.016% 1/19/2022Lenox Wealth Advisors LLC1,760$77K0.0%N/A0.024% 1/12/2022 IFP Advisors Inc4,282$189K0.0%+7.3%0.057% 11/16/2021Captrust Financial Advisors1,137$58K0.0%+29.6%0.016% 11/16/2021 Triumph Capital Management7,096$276K0.2%N/A0.098% 11/16/2021 Wealthcare Capital Management LLC5,513$280K0.0%+11.1%0.076% The Robotics Revolution has arrived … and one $7 stock could take off as a result. (Ad)Something big is brewing in Washington. According to my research, an executive order from President Trump could be just weeks away. And it holds the potential to trigger one of the most explosive tech booms in US history. At the center of it all? Robots. Not the kind that clean your house or pour you coffee. But the kind that could reshape entire industries, add $1.2 trillion per year to the US economy, and affect 65 million American lives — just in the next year.This little-known company holds nearly 100 patents and trades for around $711/15/2021Flow Traders U.S. LLC19,542$991K0.0%+257.0%0.270% 11/12/2021PSI Advisors LLC951$48K0.0%N/A0.013% 11/2/2021 Cambridge Investment Research Advisors Inc.22,773$1.16M0.0%-1.9%0.325% 10/26/2021 Mayflower Financial Advisors LLC18,767$924K0.1%+15.8%0.268% 10/21/2021 Ellis Investment Partners LLC730$37K0.0%+69.8%0.010% 8/24/2021Flow Traders U.S. LLC5,474$285K0.0%-56.6%0.084% 8/16/2021 Wealthcare Capital Management LLC4,961$258K0.0%+65.4%0.076% 8/16/2021 Wealthcare Advisory Partners LLC109,762$5.71M0.4%+23.0%1.676% 8/13/2021 Sigma Planning Corp5,633$293K0.0%-5.8%0.086% 8/11/2021Baird Financial Group Inc.47,101$2.45M0.0%+7.2%0.719% 8/1/2021 Patriot Financial Group Insurance Agency LLC5,432$283K0.1%+2,804.8%0.083% (Data available from 1/1/2016 forward) IDNA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of IDNA shares? During the previous two years, the following institutional investors and hedge funds held shares of iShares Genomics Immunology and Healthcare ETF shares: Ameriprise Financial Inc. ($1.63M), Integrated Wealth Concepts LLC ($1.16M), RiverFront Investment Group LLC ($896K), and Avior Wealth Management LLC ($603K), Cambridge Investment Research Advisors Inc. ($406K).Learn more on iShares Genomics Immunology and Healthcare ETF's institutional investors. Which institutional investors have been buying iShares Genomics Immunology and Healthcare ETF's stock? The following institutional investors have purchased iShares Genomics Immunology and Healthcare ETF's stock in the last 24 months: Avior Wealth Management LLC ($26.65K), Ameriprise Financial Inc. ($13.72K), and Cambridge Investment Research Advisors Inc. ($756.00). How much institutional buying is happening at iShares Genomics Immunology and Healthcare ETF? Institutional investors have bought a total of 41,127 shares in the last 24 months. This purchase volume represents approximately $947.90K in transactions. Related Companies Tema Electrification ETF Major Shareholders Amplify Alternative Harvest ETF Major Shareholders iShares ESG Advanced MSCI EM ETF Major Shareholders Xtrackers US National Critical Technologies ETF Major Shareholders First Trust Indxx Innovative Transaction & Process ETF Major Shareholders Global X U.S. Electrification ETF Major Shareholders Innovator Deepwater Frontier Tech ETF Major Shareholders iShares MSCI Agriculture Producers ETF Major Shareholders Sovereigns Capital Flourish Fund Major Shareholders VanEck Social Sentiment ETF Major Shareholders This page (NYSEARCA:IDNA) was last updated on 8/10/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAltucher: $900 to $108,000? Trump’s “Great Gain” Is HereJames Altucher says two recent events could trigger a historic wealth shift—one driven by a radical Trump poli...Paradigm Press | SponsoredNational 'Stock Market Reset' Coming September 30 (New WH Order)Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | SponsoredSell this, buy thatWhat you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...InvestorPlace | SponsoredGreen Light for These StocksGuess Who Washington Will Partner With Next? The U.S. government just made a bold $400 million move... beco...Stansberry Research | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredChina's 500 Million Year AdvantageThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Genomics Immunology and Healthcare ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Genomics Immunology and Healthcare ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
